News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 1236
- Sources here
- 23
- Companies here
- 17
Search results
Stored financial headlines
Active search
1236 matching headlines
Ticker or company: AGIMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Packaging Corporation Of America (PKG) Set A Shipment Record, Does It Look Fairly Valued?
Packaging Corporation of America (PKG) recently reported Q2 results, matching revenue expectations but missing on EPS and guidance, while also setting a record for corrugated shipments. Despite mixed earnings, the stock has shown strong performance over the past year. Analysts project future earnings growth …
PKG
main company
Sharemaestro market context
Trend signal active
52 weeks +23.0%
Agilon Health (AGL) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations - Evan Smith Chief Executive Officer - Timothy O'Rourke Chief Financial Officer - Jeffrey Schwaneke Full Conference Call Transcript Operator: Hello, everyone. Thank …
AGL
main company
Sharemaestro market context
Trend signal active
52 weeks +191.4% · Next-week setup positive 57.8%
QT Imaging Holdings affirms $39.000M FY26 sales guidance
QT Imaging Holdings (NASDAQ: QTI) has reaffirmed its FY26 sales guidance at $39.000 million, which is consistent with prior reports but $0.200 million below the analyst consensus of $39.200 million. This stable guidance indicates a consistent operational outlook for the company, despite a slight …
QTI
main company
Sharemaestro market context
Stored weekly price path
29 weeks -49.1% · Next-week setup negative 38.9%
Nano-X Imaging (NASDAQ: NNOX) Optimizes Nanox.AI Medical Imaging Framework for Intel Core Ultra Processors
Nano-X Imaging Ltd. (NASDAQ: NNOX) announced that its subsidiary Nanox.AI has optimized its medical imaging AI application framework for Intel Core Ultra processors using the Intel OpenVINO toolkit. This optimization enables healthcare facilities to deploy CT imaging AI applications on on-premise edge devices, keeping …
NNOX
main company
Sharemaestro market context
Price below Trend Line
52 weeks -75.4% · Next-week setup negative 44.9%
Lumexa Imaging Holdings Reports Q2 2026 Financial Results in SEC 8-K Filing
Lumexa Imaging Holdings, Inc. filed an 8-K report with the SEC on August 12, 2026, announcing its financial results for the quarter ended June 30, 2026. The report includes a press release (Exhibit 99.1) detailing the results of operations and financial condition, as well …
LMRI
main company
Sharemaestro market context
Price above Trend Line
36 weeks -35.1% · Next-week setup negative 28.5%
Earnings call transcript: QT Imaging misses Q2 2026 profit forecast
QT Imaging (QTI) reported strong Q2 2026 financial results, with revenue increasing by 103% year-over-year to $7.4 million, driven by higher scanner shipments. The company affirmed its 2026 revenue guidance of approximately $39 million, more than double the 2025 revenue, and is expanding its …
QTI
main company
Sharemaestro market context
Stored weekly price path
29 weeks -49.1% · Next-week setup negative 38.9%
Lumexa: Q2 Earnings Snapshot
Lumexa Imaging Holdings Inc. (LMRI) reported Q2 earnings of $2.7 million, or 3 cents per share. Adjusted earnings were 20 cents per share, and revenue reached $264.2 million, exceeding analyst forecasts. The company projects full-year earnings between 71 cents and 77 cents per share, …
LMRI
main company
Sharemaestro market context
Price above Trend Line
36 weeks -35.1% · Next-week setup negative 28.5%
QT Imaging (QTI) Q2 2026 Earnings Call Transcript
QT Imaging (QTI) reported strong Q2 2026 financial results, with revenue increasing by 103% year-over-year to $7.4 million, driven by higher scanner shipments. The company affirmed its 2026 revenue guidance of approximately $39 million, more than double the 2025 revenue, and is expanding its …
QTI
main company
Sharemaestro market context
Stored weekly price path
29 weeks -49.1% · Next-week setup negative 38.9%
Earnings Flash (LMRI) Lumexa Imaging Holdings, Inc. Reports Q2 Revenue $264.2M, vs. FactSet Est of $263.1M
Lumexa Imaging Holdings, Inc. (LMRI) announced its Q2 revenue of $264.2 million, surpassing FactSet's estimate of $263.1 million. The company also reiterated its full-year 2026 revenue guidance, projecting a range of $1.045 billion to $1.097 billion against an estimate of $1.066 billion. Lumexa Imaging …
LMRI
main company
Sharemaestro market context
Price above Trend Line
36 weeks -35.1% · Next-week setup negative 28.5%
Lumexa Imaging Announces Second Quarter 2026 Results
Lumexa Imaging (Nasdaq: LMRI) reported strong second-quarter 2026 results, showing a 5.1% increase in consolidated revenues to $264.2 million and a net income of $2.7 million. The company also updated its full-year 2026 outlook, reiterating revenue guidance and narrowing its Adjusted EBITDA range, reflecting …
LMRI
main company
Sharemaestro market context
Price above Trend Line
36 weeks -35.1% · Next-week setup negative 28.5%
QT Imaging Holdings (QTI) doubles Q2 revenue but books $11.1M net loss
QT Imaging Holdings reported a 103% increase in Q2 revenue to $7.4 million, driven by increased shipments of Breast Acoustic CT scanners. Despite this growth and reaffirmed 2026 revenue guidance of $39 million, the company posted an $11.1 million net loss, largely due to …
QTI
main company
Sharemaestro market context
Stored weekly price path
29 weeks -49.1% · Next-week setup negative 38.9%
Footprint Reshuffle and Steady Dividend Could Be A Game Changer For Graphic Packaging Holding (GPK)
Graphic Packaging Holding Company (GPK) reported weaker Q2 2026 earnings but maintained its dividend and reaffirmed full-year sales guidance. The company is optimizing its footprint by divesting and closing facilities to improve cost efficiency. This strategic move aims to consolidate production capacity and stabilize …
GPK
main company
Sharemaestro market context
Price above Trend Line
52 weeks -48.8%
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Agios Pharmaceuticals, Inc. (AGIO) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Agios Pharmaceuticals, Inc. (AGIO) following a significant stock drop. The investigation stems from Agios's announcement that its Phase 2 trial for tebapivat in sickle cell disease did not meet the necessary differentiation for continued …
AGIO
main company
Sharemaestro market context
Trend signal active
52 weeks -13.5%
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3
Agilent Technologies Inc. announced that the FDA has approved the expanded use of its PD-L1 IHC 22C3 pharmDx for Dako Omnis platform. This approval allows for identifying patients with esophageal squamous cell carcinoma, triple-negative breast cancer, cervical cancer, and gastric or gastroesophageal junction adenocarcinoma …
A
main company
Sharemaestro market context
Trend signal active
52 weeks +22.8% · Next-week setup negative 44.0%
Agilent Technologies, Inc. Stock 12‑Month Price Target Raised to $160.17, Implies 7% Upside
The average 12-month price target for Agilent Technologies, Inc. (A) stock has been raised from $159.33 to $160.17 by 18 analysts, with forecasts ranging from $135 to $185 per share. This new target implies a potential upside of approximately 7% from the August 11 …
A
main company
Sharemaestro market context
Trend signal active
52 weeks +22.8% · Next-week setup negative 44.0%
Q4 2025 Agios Pharmaceuticals Inc Earnings Call Transcript
Agios Pharmaceuticals reported strong Q4 and full-year 2025 results, driven by the successful launch of AQVESME for thalassemia and robust PYRUKYND revenue. The company ended 2025 with $1.2 billion in cash, has a clear path to profitability, and is advancing its pipeline, including a …
AGIO
main company
Sharemaestro market context
Trend signal active
52 weeks -13.5%
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Agilon Health (AGL) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the …
AGL
main company
Sharemaestro market context
Trend signal active
52 weeks +191.4% · Next-week setup positive 57.8%
Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating
Morgan Stanley has increased its price target for Agilent Technologies (A) to $175, up from $160, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook for the company's financial performance and market position.
A
main company
Sharemaestro market context
Trend signal active
52 weeks +22.8% · Next-week setup negative 44.0%
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.15% in agilon health, inc. (AGL) common stock through a Schedule 13G/A filing. This stake amounts to 692,541 shares, with shared voting power over 666,033 shares …
AGL
main company
Sharemaestro market context
Trend signal active
52 weeks +191.4% · Next-week setup positive 57.8%
Magic Empire Global prices private placement of 20,000,000 Class A shares at $0.25 each, raising $5 million
Magic Empire Global has completed a private placement of 20,000,000 Class A ordinary shares at $0.25 each, successfully raising $5 million. The unregistered sale was finalized on July 20, 2026, through a securities purchase agreement with various purchasers. This news brief was generated by …
MEGL
main company
Sharemaestro market context
Trend signal active
52 weeks -10.9% · Next-week setup negative 34.2%